Nambiraja A et al C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center. Childs Nerv Syst. (2021), 10.1007/s00381-020-04973-0. IHC; Human. Read more (PubMed: 33236184)

Esteve-Codina A et al RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma. Clin Cancer Res. (2021), 10.1158/1078-0432.CCR-20-2141. IHC; Human. Read more (PubMed: 33106291)

Bressan RB et al Regional identity of human neural stem cells determines oncogenic responses to histone H3.3 mutants. Cell Stem Cell. (2021), 10.1016/j.stem.2021.01.016. IHC; Human. Read more (PubMed: 33631116)

Minasi S et al Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma. Childs Nerc Syst. (2020), 10.1007/s00381-020-04933-8. IHC; Human. Read more (PubMed: 33128602)

Pathania M et al. H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas Cancer Cell (2017) 10.1016/j.ccell.2017.09.014. IHC-P; Human. Read more (PubMed: 29107533)

Yamamoto H et al. Diagnostic utility of histone H3.3G34 W, G34R, and G34 V mutant-specific antibodies for giant cell tumors of bone. Human Pathology (2017) 10.1016/j.humpath.2017.11.020. IHC; Human. Read more (PubMed: 29241742)

---

Post time: 2024-07-31 15:24:18

---

Previous: References for ARv7 Splice Variant antibody [RM7]

Next: References for Histone H3.3 G34V Mutant antibody [RM307]